Visibly, formerly known as Opternative, is no longer making its online refractive vision test available on its website, reflecting an Aug. 8 notice by the Food and Drug Administration (FDA). Recall notices are issued by companies when told by the FDA a product is being offered in violation of federal law.
The MOA and its Legislative Committee has stood steadfast in putting teeth behind the Michigan laws it helped to create in protecting the public from Visibly (formerly Opternative). We applaud the AOA’s efforts and the FDA in its most recent action. The MOA will continue to help enforce the state laws that it fought to diligently to create.
"Optometrists and other physicians know that eye exams are essential care and that new health technologies must always enhance the doctor-patient relationship and help deliver improved outcomes," AOA President Barbara L. Horn, O.D., says. Click here for more information about the FDA recall and AOA’s formal complaints to the FDA.